Research reviewed by Gram found that combining a ketogenic diet with intermittent fasting boosted immunotherapy in animal tumor models that usually resist it. A 2026 Cancer Research study linked this effect to the gut bacterium Odoribacter splanchnicus, which restored tumor control when added alone. Human confirmation is still needed.
According to research reviewed by Gram, combining a ketogenic diet with intermittent fasting may help the immune system attack tumors that normally resist immunotherapy. In this laboratory study published in Cancer Research in 2026, the combined approach lowered blood sugar, kept tumors supplied with an amino acid called glutamine, and helped immune cells called T cells and natural killer cells work harder against cancer. The researchers also found that gut bacteria played a key role. One bacterium, Odoribacter splanchnicus, was enough to restore the benefit in animals that had lost their normal gut microbes. Human data sets showed similar patterns between gut bacteria levels and how well patients responded to immunotherapy. These findings are early and come mostly from animal models, so they do not yet show that this diet works for people with cancer.
Key Statistics
A 2026 laboratory study published in Cancer Research found that combining a ketogenic diet with intermittent fasting enhanced the effect of anti-PD-1 immunotherapy in tumor models that usually resist it.
A 2026 Cancer Research study found that the gut bacterium Odoribacter splanchnicus was sufficient to restore tumor control and T cell activity in animals whose normal gut microbes had been depleted.
A 2026 Cancer Research study reported that the combined diet and fasting approach increased the activity of glutamine transporters SLC38A1 and SLC38A2 in tumor-infiltrating CD8+ T cells and natural killer cells.
The Quick Take
- What they studied: Whether combining a ketogenic diet with intermittent fasting could make hard-to-treat tumors more responsive to a type of cancer immunotherapy, and how gut bacteria are involved.
- Who participated: The main experiments used laboratory animals with tumors. The exact number of animals was not stated in the summary provided. The researchers also looked at existing human patient data sets to check whether similar patterns appeared in people.
- Key finding: The combined diet and fasting approach boosted the effect of an immunotherapy drug called anti-PD-1 in tumors that usually ignore it. Immune cells became more active, and a specific gut bacterium, Odoribacter splanchnicus, appeared to be essential for this effect.
- What it means for you: This research is at an early stage. It does not mean that anyone should change their diet to treat cancer. Anyone considering a ketogenic diet or fasting during cancer treatment should talk with their oncology team first, since these approaches can affect health and treatment in important ways.
The Research Details
The researchers mainly used laboratory mice with tumors that were hard for the immune system to attack. They compared animals on a ketogenic diet, animals using intermittent fasting, and animals that received both together. This allowed them to see whether the combination had effects that neither approach produced on its own.
To understand how the approach worked, the team measured blood sugar, nutrients inside tumors, and the activity of immune cells. They also used a method called single-cell analysis, which examines the genetic activity of individual immune cells. This showed how the cells changed under the combined diet.
To test the role of gut bacteria, the researchers wiped out the normal microbes in some animals and then transferred gut bacteria from other animals. They also added single bacterial species one at a time to find out which ones mattered most. Finally, they checked whether similar links between gut bacteria, nutrients, and immunotherapy response appeared in publicly available human data.
Using animal models lets scientists control diet, gut bacteria, and tumor type very precisely, which is hard to do in people. Testing one bacterium at a time shows cause and effect more clearly than simply observing that certain bacteria are common in patients who respond well. Comparing the combined approach with each approach alone also shows whether the benefit is truly new.
The study uses several methods that support its findings, including controlled experiments, gut bacteria transfers, and single-cell analysis. Checking results against human data sets adds some support. However, animal studies do not always predict results in people, and the human data were observational, meaning they show links rather than proof that the diet or bacteria caused the outcome. Sample sizes and full statistical details were not included in the summary provided, so readers should look at the full paper before drawing firm conclusions.
What the Results Show
The combined ketogenic diet and fasting plan lowered blood sugar throughout the body. Yet the nutrient glutamine stayed available inside tumors. Glutamine is an amino acid that immune cells use as fuel, so keeping it available seems to help them keep fighting.
The diet also increased the activity of two transporters, proteins that move glutamine into cells. These transporters, called SLC38A1 and SLC38A2, were boosted in two important immune cell types: CD8+ T cells, which directly destroy cancer cells, and natural killer cells, which also attack abnormal cells. With more fuel and more transporters, these cells appeared more active and produced signals that help fight tumors.
When the researchers wiped out gut bacteria, the anti-tumor benefit of the combined approach was weakened. Tumors still had high glutamine levels, which suggests the gut microbes were doing more than just supplying nutrients. Transferring bacteria from other animals and adding single species one by one pointed to Odoribacter splanchnicus as a bacterium that could restore tumor control on its own.
The researchers also found that this bacterium was linked to changes in polyamines, small molecules involved in cell growth, and to a compound called indole-3-lactic acid. These molecules appeared to support long-lasting T cell function through a route separate from glutamine. Together, these pathways suggest that diet and gut microbes work as a team to strengthen the immune response.
The combined approach reduced signs of T cell exhaustion, a state in which immune cells become worn out and stop working well. Cells in the combined group showed more effective fighting behavior and less of this worn-out pattern. The researchers also reported that the diet worked in several tumor models that were resistant to immunotherapy, suggesting the effect may not be limited to one cancer type. Human data sets showed that patterns linking glutamine levels and Odoribacter abundance matched better immunotherapy response, though these were associations rather than tests of treatment.
Earlier research has suggested that ketogenic diets and fasting can affect tumor growth and immune activity, and that gut bacteria can influence how patients respond to immunotherapy. This study adds a more specific picture by showing that the combination works better than either approach alone, and by naming one bacterium and a set of metabolic pathways that appear to link diet to immune strength. It builds on a growing field of research on how diet, gut microbes, and immunity interact, but it still needs to be confirmed in larger and more diverse studies.
Most of the evidence comes from animal experiments, and mice do not perfectly match human biology. Human evidence was drawn from existing data sets, which can show links but cannot prove that the diet or bacteria caused better results. The summary did not report the number of animals or patients, which makes it harder to judge how reliable the results are. The ketogenic diet and fasting used in the study may also differ from what people can safely follow, and results may vary depending on the type of cancer, the immunotherapy drug, and a person’s overall health.
The Bottom Line
Based on current evidence, there is no proven recommendation for people with cancer to adopt a ketogenic diet with fasting. The findings are promising and worth studying in clinical trials. Confidence is low to moderate at this stage because the strongest evidence comes from animal studies. Anyone interested in this approach should discuss it with their care team rather than making changes on their own.
Cancer researchers, oncologists, and scientists studying the gut microbiome and immunotherapy should pay close attention to these findings. Patients receiving immunotherapy may find the research interesting, but they should not change their diet without medical guidance. People who are underweight, pregnant, diabetic, or have a history of eating disorders should avoid strict ketogenic diets or prolonged fasting unless a doctor supervises them. The results do not apply to people without cancer as a treatment strategy.
Findings from animal studies usually take years to test in people. Clinical trials would need to check safety, the right diet plan, and whether the benefit holds up in patients. Realistically, it may be several years before doctors know whether this approach has a place in cancer care. Anyone following a medically supervised diet during treatment may notice changes in energy, weight, or blood sugar within days to weeks, but any effect on cancer would need careful clinical testing.
Frequently Asked Questions
Can a ketogenic diet and fasting help immunotherapy work better for cancer?
A 2026 Cancer Research study found that combining a ketogenic diet with intermittent fasting improved the response to anti-PD-1 immunotherapy in animal tumor models. The results are promising but early, and they have not yet been confirmed in clinical trials with people.
What is Odoribacter splanchnicus and why does it matter for cancer treatment?
Odoribacter splanchnicus is a bacterium that lives in the gut. In animal studies, adding it alone restored tumor control and immune cell activity in animals that lacked normal gut microbes. Researchers are still working out whether it could play a similar role in people.
Is it safe to try a keto diet with fasting during cancer treatment?
Ketogenic diets and fasting can affect energy, blood sugar, weight, and medication effects, so they are not safe for everyone. Anyone with cancer should discuss any diet change with their oncology team before starting, especially during immunotherapy or other treatment.
Does this research prove that diet can cure cancer?
No single study can prove a cure. This research was mostly done in animals and shows a possible biological pathway linking diet, gut bacteria, and immune strength. Human clinical trials would be needed to determine whether the approach is safe and effective for people.
Want to Apply This Research?
- Track daily eating window length in hours, total daily calories, and weekly body weight. If a user is working with a doctor on a supervised plan, also log fasting blood sugar readings when a clinician has provided them, and share these records at appointments.
- Encourage users who are already interested in intermittent fasting or low-carb eating for general health to first consult a healthcare provider, then set a consistent eating window and log meals with protein and fiber. Remind users that gut health also depends on eating a variety of plant foods, which supports a more diverse gut microbiome.
- Use monthly summaries to look for trends in weight, energy, sleep, and symptoms like nausea or dizziness, and flag any sudden changes for medical review. Keep records of any medical treatment, including immunotherapy schedules, so users and their doctors can see how diet and treatment line up over time. Update the app as new clinical trial results become available.
This article summarizes early research, much of which was conducted in laboratory animals, and does not establish that a ketogenic diet, fasting, or any bacterial treatment is safe or effective for people with cancer. It is not medical advice. Anyone with cancer or another health condition should consult their oncology team or healthcare provider before making changes to diet, fasting, or treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.